Combined treatment of exudative age related macular degeneration with photodynamic therapy and intravitreal triamcinolone.
Choroidal neovascularization (CNV) secondary to age related macular degeneration is among the leading causes of legal blindness in developed countries. Photodynamic therapy (PDT) with verteporfin induces CNV closure causing little damage to healthy tissue, but the need to re-treat may lead to low final visual acuity at an unacceptable cost. The association of intravitreous triamcinolone or antiangiogenic drugs with PDT has been used in order to reduce these limitations of the therapy. The combination of PDT and intravitreous triamcinolone, its complications and outcome at one and two-year follow-up are discussed.
Ruiz-Moreno
José M
JM
Department of Ophthalmology, Miguel Hernández University School of Medicine, Alicante, Spain. m.ruiz@umh.es
Montero
Javier A
JA